Tag: FDA Purple Book
Jan, 28 2026
FDA Listing for Biosimilars: How They Are Evaluated and Approved
The FDA doesn't rate biosimilars like generics-they undergo a rigorous scientific review to prove they're highly similar to the original biologic. Learn how approval works, what 'interchangeable' means, and why biosimilars are changing access to expensive treatments.